Seven Programme Topics

The 2019 DIA Europe Programme Topics pose questions about the future of treatment development, and bring together cross-functional leaders to propose answers.

• Topic 1: How Can Different Stakeholders Support Regulatory System Optimisation?

  João Duarte
  Associate Director, Europe Regulatory Policy & Intelligence, Takeda, UK
  Camille Metais
  Senior Director, Regulatory Affairs, Alexion, Switzerland

  View Sessions

  Go back to top

• Topic 2: Evolution of Science and Policy – Where Are We Heading?

  Klaus Cichutek
  President, Paul-Ehrlich-Institut, Germany
  Esteban Herrero-Martinez
  Director, Regulatory Policy & Intelligence, AbbVie, UK

  View Sessions

  Go back to top

• Topic 3: Towards 2020 and Beyond in Pharmacovigilance

  Gaby Danan
  Pharmacovigilance Expert, France
  Sabine Straus
  PRAC Chair, Staff Member, Medicines Evaluation Board (MEB), Netherlands

  View Sessions

  Go back to top

• Topic 4: Modern Clinical Research and Paradigm Shift

  Rob Hemmings
  Statistics and Pharmacokinetics Unit Manager, Medicines and Healthcare products Regulatory Agency (MHRA), UK
  Peter Schueler
  Senior Vice President, Medical and Safety Services, ICON, Germany

  View Sessions

  Go back to top

• Topic 5: Transforming Medical Affairs and Communications

  View Sessions

  Go back to top

• Topic 6: Combatting Fragmentation in Access to Medicines – Shaping the System

  Claudine Sapède
  Global HTA & Payment Policy Lead, F. Hoffmann-La-Roche, Switzerland
  Koen Torfs
  Head of Market Access & Pricing, Actelion, Switzerland

  View Sessions

  Go back to top

• Topic 7: Digital Disruptors Changing the Game

  Isabelle de Zegher
  Vice President, Integrated Solution, PAREXEL Informatics, Belgium
  Chris Walker
  Vice President, European Head of Regulatory Affairs & UK Sites Head, Amgen Ltd., UK

  View Sessions

  Go back to top

• Additional Hot Topics and Regional Updates

  View Regional Updates

  Go back to top